Literature DB >> 19437103

PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells.

Jiachi Ma1, Hirozumi Sawai, Nobuo Ochi, Yoichi Matsuo, Donghui Xu, Akira Yasuda, Hiroki Takahashi, Takehiro Wakasugi, Hiromitsu Takeyama.   

Abstract

Phosphoinositide 3-kinase (PI3K) pathway exerts its effects through Akt, its downstream target molecule, and thereby regulates various cell functions including cell proliferation, cell transformation, apoptosis, tumor growth, and angiogenesis. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) has been implicated in regulating cell survival signaling through the PI3K/Akt pathway. However, the mechanism by PI3K/PTEN signaling regulates angiogenesis and tumor growth in vivo remains to be elucidated. Vascular endothelial growth factor (VEGF) plays a pivotal role in tumor angiogenesis. The effect of PTEN on VEGF-mediated signal in pancreatic cancer is unknown. This study aimed to determine the effect of PTEN on both the expression of VEGF and angiogenesis. Toward that end, we used the siRNA knockdown method to specifically define the role of PTEN in the expression of VEGF and angiogenesis. We found that siRNA-mediated inhibition of PTEN gene expression in pancreatic cancer cells increase their VEGF secretion, up-modulated the proliferation, and migration of co-cultured vascular endothelial cell and enhanced tubule formation by HUVEC. In addition, PTEN modulated VEGF-mediated signaling and affected tumor angiogenesis through PI3K/Akt/VEGF/eNOS pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19437103     DOI: 10.1007/s11010-009-0154-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

1.  Repression of PTEN phosphatase by Snail1 transcriptional factor during gamma radiation-induced apoptosis.

Authors:  Maria Escrivà; Sandra Peiró; Nicolás Herranz; Patricia Villagrasa; Natàlia Dave; Bàrbara Montserrat-Sentís; Stephen A Murray; Clara Francí; Thomas Gridley; Ismo Virtanen; Antonio García de Herreros
Journal:  Mol Cell Biol       Date:  2008-01-02       Impact factor: 4.272

Review 2.  PTEN: life as a tumor suppressor.

Authors:  L Simpson; R Parsons
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

3.  PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration.

Authors:  Carmen J Marsit; Shichun Zheng; Kenneth Aldape; Philip W Hinds; Heather H Nelson; John K Wiencke; Karl T Kelsey
Journal:  Hum Pathol       Date:  2005-07       Impact factor: 3.466

4.  Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma.

Authors:  D Giri; M Ittmann
Journal:  Hum Pathol       Date:  1999-04       Impact factor: 3.466

5.  PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects.

Authors:  Jianhua Huang; Christopher D Kontos
Journal:  J Biol Chem       Date:  2002-01-09       Impact factor: 5.157

6.  High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.

Authors:  V Stambolic; M S Tsao; D Macpherson; A Suzuki; W B Chapman; T W Mak
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

7.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

8.  PTEN promoter methylation in sporadic thyroid carcinomas.

Authors:  Francisco Alvarez-Nuñez; Elena Bussaglia; Didac Mauricio; Juan Ybarra; Monica Vilar; Enrique Lerma; Alberto de Leiva; Xavier Matias-Guiu
Journal:  Thyroid       Date:  2006-01       Impact factor: 6.568

9.  PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate.

Authors:  J T Dong; T W Sipe; E R Hyytinen; C L Li; C Heise; D E McClintock; C D Grant; L W Chung; H F Frierson
Journal:  Oncogene       Date:  1998-10-15       Impact factor: 9.867

Review 10.  PI3K/PTEN signaling in tumorigenesis and angiogenesis.

Authors:  Bing-Hua Jiang; Ling-Zhi Liu
Journal:  Biochim Biophys Acta       Date:  2007-09-29
View more
  67 in total

Review 1.  Molecular biology of pancreatic cancer.

Authors:  Miroslav Zavoral; Petra Minarikova; Filip Zavada; Cyril Salek; Marek Minarik
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

2.  PTEN inhibits proliferation and functions of hypertrophic scar fibroblasts.

Authors:  Liang Guo; Liang Chen; Sheng Bi; Linlin Chai; Zengxiang Wang; Chuan Cao; Ling Tao; Shirong Li
Journal:  Mol Cell Biochem       Date:  2011-10-12       Impact factor: 3.396

3.  The novel miR-9500 regulates the proliferation and migration of human lung cancer cells by targeting Akt1.

Authors:  J K Yoo; H Y Jung; J M Lee; H Yi; S-H Oh; H Y Ko; H Yoo; H-R Kim; H Song; S Kim; J K Kim
Journal:  Cell Death Differ       Date:  2014-03-21       Impact factor: 15.828

4.  Anti-angiogenic action of PPARγ ligand in human umbilical vein endothelial cells is mediated by PTEN upregulation and VEGFR-2 downregulation.

Authors:  Ki Young Kim; Jin Hee Ahn; Hyae Gyeong Cheon
Journal:  Mol Cell Biochem       Date:  2011-07-17       Impact factor: 3.396

Review 5.  Reactive oxygen species in cancer.

Authors:  Geou-Yarh Liou; Peter Storz
Journal:  Free Radic Res       Date:  2010-05

Review 6.  The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells.

Authors:  M R Moniri; L-J Dai; G L Warnock
Journal:  Cancer Gene Ther       Date:  2014-01-03       Impact factor: 5.987

7.  Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study.

Authors:  Vasilios Karavasilis; Epaminontas Samantas; Georgia-Angeliki Koliou; Anna Kalogera-Fountzila; George Pentheroudakis; Ioannis Varthalitis; Helena Linardou; Grigorios Rallis; Maria Skondra; Georgios Papadopoulos; George Papatsibas; Joseph Sgouros; Athina Goudopoulou; Konstantine T Kalogeras; Christos Dervenis; Dimitrios Pectasides; George Fountzilas
Journal:  Target Oncol       Date:  2018-12       Impact factor: 4.493

Review 8.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

9.  T11TS impedes glioma angiogenesis by inhibiting VEGF signaling and pro-survival PI3K/Akt/eNOS pathway with concomitant upregulation of PTEN in brain endothelial cells.

Authors:  Debanjan Bhattacharya; Manoj Kumar Singh; Suhnrita Chaudhuri; Sagar Acharya; Anjan Kumar Basu; Swapna Chaudhuri
Journal:  J Neurooncol       Date:  2013-03-08       Impact factor: 4.130

10.  FOXC2 is up-regulated in pancreatic ductal adenocarcinoma and promotes the growth and migration of cancer cells.

Authors:  Lei Cui; Shengchun Dang; Jianguo Qu; Zhengfa Mao; Xuqing Wang; Jianxin Zhang; Jixiang Chen
Journal:  Tumour Biol       Date:  2016-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.